TickerFactsScreenerDevelopers

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2005: -$14.6K2006: $552.6K2007: $376.9K2008: -$323.5K2009: $1.30M2010: $1.74M2011: $79.0K2012: $1.49M2013: $236.3K2014: $265.9K2015: $312.3K2016: $214.8K2017: $995.0K2018: $4.13M2019: $2.43M2020: $5.01M2021: $4.79M2022: $5.17M2023: $3.99M2024: $827.2K2025: $9.66M$9.66M
2005Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$9.66M+1068.3%
2024$827.2K-79.3%
2023$3.99M-22.7%
2022$5.17M+7.8%
2021$4.79M-4.4%
2020$5.01M+105.9%
2019$2.43M-41.0%
2018$4.13M+314.6%
2017$995.0K+363.3%
2016$214.8K-31.2%
2015$312.3K+17.5%
2014$265.9K+12.5%
2013$236.3K-84.2%
2012$1.49M+1787.9%
2011$79.0K-95.4%
2010$1.74M+33.4%
2009$1.30M+502.1%
2008-$323.5K-185.8%
2007$376.9K-31.8%
2006$552.6K+3878.5%
2005-$14.6K—